Following years of growth and favourable market trends, 2014 will see the global life sciences industry facing the so-called ‘new normal’. Markets are changing and life science companies must respond by adopting new business models. Dominic Graham of Kelly Services discusses the key challenges that these companies will likely face in terms of recruitment, along with suggestions on how they can meet these head on and attempt to mitigate risk.
https://international-pharma.com/wp-content/uploads/2014/03/Making-life-sciences…pdf.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Making Life Sciences a Magnet for Talent in 2014
